ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases

Author:

Jacobs Michael R.12,Abdelhamed Ayman M.12,Good Caryn E.12,Rhoads Daniel D.12ORCID,Hujer Kristine M.34,Hujer Andrea M.34,Domitrovic T. Nicholas34,Rudin Susan D.34,Richter Sandra S.5,van Duin David6ORCID,Kreiswirth Barry N.7,Greco Chris8,Fouts Derrick E.8,Bonomo Robert A.3491011

Affiliation:

1. Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA

2. Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA

3. Department of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

4. Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA

5. Department of Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA

6. Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA

7. Public Health Research Institute, Rutgers New Jersey Medical School, Newark, New Jersey, USA

8. J. Craig Venter Institute, Rockville, Maryland, USA

9. Department of Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio, USA

10. Department of Pharmacology, Case Western Reserve University, Cleveland, Ohio, USA

11. Department of Biochemistry, Case Western Reserve University, Cleveland, Ohio, USA

Abstract

The activity of the siderophore cephalosporin cefiderocol is targeted against carbapenem-resistant Gram-negative bacteria. In this study, the activity of cefiderocol against characterized carbapenem-resistant Acinetobacter baumannii complex, Stenotrophomonas maltophilia , Pseudomonas aeruginosa , and Enterobacteriaceae strains was determined by microdilution in iron-depleted Mueller-Hinton broth.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

U.S. Department of Veterans Affairs

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference30 articles.

1. World Health Organization. 2017. Antibacterial agents in clinical development. An analysis of the antibacterial clinical development pipeline, including tuberculosis. Report WHO/EMP/IAU/201711. World Health Organization, Geneva, Switzerland.

2. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States 2013. Centers for Disease Control and Prevention Atlanta GA. https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf.

3. Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group

4. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality

5. Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatment

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3